MedTrace Logo

Effects of Pursed Lip Breathing With and Without Mat Pilates Training in Obese Women

NCT05655624 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-02-01

No results posted yet for this study

Summary

Obesity is defined as BMI more than or equal to 30kg/m2. It is responsible for manifestation of serious health problem. Accumulation of adipose tissue in thorax and abdomen causes stiffness of chest, reduction in lung compliance and favoring airway closure. As result, reduction in lung volume and capacity occurs which requires increased breathing to maintain adequate oxygenation. These changes lead to limitations in activities of daily life. A Randomized Control study will be conduct to see the effects of Pilates exercise and pursed lip breathing to improve the breathing and thoracoabdominal expansion. The study will be completed within 10 months after approval of synopsis. The sample size of 34 subjects will be taken: 17 with Pilates method and 17 without Pilates method with 12% attrition rate. Pre assessment and Post assessment will be made through IPAQ questionnaire for physical activity measurement, Borg's scale (CR-10) for dyspnea measurement and Cirtometry for thoracoabdominal expansion. Study will be conducted at Star gym for women Al-Rehman Garden community, Lahore. Data will be analyzed through SPSS 25.

Conditions

  • Obese Women

Interventions

OTHER

Pursed lip Breathing along Mat Pilates

Experimental Group: will be treated with Pursed lip Breathing along Mat Pilates Training.

OTHER

pursed lip breathing without Mat Pilates Training

Control Group will be treated pursed lip breathing without Mat Pilates Training

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Hafiza Muriam Ghani, MSCPPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2022-12-31
Completion
2023-01-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05655624 on ClinicalTrials.gov